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Harald Bruhn and Jens Frahm* 
Max-Planck-Institut fur biophysikalische Chemie Postfach 2841, D-3400 Gottingen, Germany 
Localized 'H NMR spectra of human brain in uiuo are affected by signal overlap, strong spin-spin coupling, and 
complex J modulation, and therefore differ considerably from those obtained at higher magnetic fields. This 
paper deals with the assignment of 'H NMR resonances of cerebral metabolites under the experimental 
conditions used for human investigations. Conventional 7.0-T FID spectra and 2.0 T localized, short echo time 
STEAM spectra (TE=20ms) of aqueous metabolite solutions are compared to in uiuo brain spectra of human 
volunteers and patients. In addition to singlet resonances from N-acetyl aspartate (NAA), creatines, and 
cholines, short echo time STEAM spectra exhibit multiplets due to the NAA aspartyl group, glutamate, taurine, 
and myo-inositol. Enhanced levels of cerebral glutamine are detected in patients with liver cirrhosis. For the first 
time elevated levels of brain glucose are observed in patients with diabetes mellitus. 
INTRODUCTION 
Recent progress in localized 'H NMR spectroscopy has 
led to considerable improvement with respect to its 
technical feasibility, achievable spectral quality, and 
clinical applicability. In particular, stimulated echo 
(STEAM) localization sequences with short echo times 
reveal a large number of components in spectra of 
human brain in u ~ u o . ' - ~  The respective resonances are 
linked to cerebral metabolites that are of major rele- 
vance for the biochemistry of the functioning brain. 
Thus, NMR spectroscopy not only offers noninvasive 
strategies for a clinical diagnosis based on metabolic 
information, but opens the way to completely new 
areas of research such as in uiuo neurochemistry in 
man. 
In order to fully develop the recent methodological 
achievements into valuable tools for studies of both 
normal and pathological metabolism, the spectroscopic 
characterization of a localized region of tissue must be 
transformed into a metabolic characterization in terms 
of absolute concentrations. The first step in this direc- 
tion is an unambiguous identification of metabolite 
resonances in spectra that are acquired under opti- 
mized experimental conditions. These conditions not 
only require a reliable localization technique, they 
further necessitate the use of short echo times to detect 
resonances with small T2 relaxation times and to reduce 
J modulation effects on strongly spin-coupled reso- 
nances. It is the purpose of this paper to identify 'H 
NMR visible metabolites that are observable in human 
brain in uiuo using state-of-the-art NMR technology. 
METHODS 
High-field 'H NMR spectra (300 MHz) of aqueous 
solutions (deuterium oxide) of metabolites and per- 
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chloric acid extracts of rat brain tissue were obtained 
at 7.0 T (Bruker MSL 300, Karlsruhe, Germany). The 
model solutions were measured at room temperature 
with metabolite concentrations of S100mM. In all 
cases the pH was adjusted to 7.1-7.3 using a phosphate 
buffer. Spectra were acquired within 24h of prep- 
aration. The high-field results were compared to 2.OT 
(Siemens Magnetom, Erlangen, Germany) localized, 
water-suppressed 'H NMR spectra (84.5 MHz) of both 
aqueous solutions of metabolites and human subjects. 
The spectra were acquired using a STEAM localization 
sequence in conjunction with three CHESS cycles for 
water suppression 
[90"(CHESS) - l3 - 90"(slice 1) - TE/2 - 90"(slice 2) 
- TM - 90"(slice 3) - TE/2 - STE. 
Technical details have been described previously.' The 
echo time was set to TE = 20 ms and the middle interval 
to TM = 30 ms. The second half of the stimulated echo 
signal STE was acquired (1024 ms) with a receiver 
bandwidth of *lo00 Hz (2k complex data samples, 
dwell time 0.5 ms). Human brain studies were per- 
formed using the same STEAM sequence as for phan- 
toms. Spectra were acquired within measuring times of 
6.5 min accumulating either 64 scans (TR = 6OOO ms), 
128 scans (TR = 3000 ms), or 256 scans (TR = 1500 ms) 
for signal averaging. Volumes-of-interest (VOI) of 
between 8 and 18 mL were localized in gray and white 
matter regions of the brain. Spectral processing 
involved zero filling to 4k data points, Gaussian 
multiplication of the time-domain data (1.2 Hz line- 
broadening), Fourier transformation, and zero and first 
order phase correction. In general, the spectral resolu- 
tion corresponded to f O . O 1  ppm. 
Localized 'H NMR spectroscopy was performed sub- 
sequent to a fast scan NMR imaging protocol4 com- 
bining TI-weighted FLASH images (eight slices, 
TE = 6 ms, TR = 100 ms, flip angle 70°, one excitation, 
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total measuring time 26 s) and T,-weighted CE-FAST 
images (single slice, TE = -6 ms, TR = 13.8 ms, flip 
angle 40°, four excitations, measuring time 14s) to 
determine the exact position of the VOI in all three 
orientations. A combined imaging and spectroscopy 
study was completed with a total investigational time of 
45-75 min yielding spectra at  two to four different 
locations and with at least two different repetition 
times. Informed consent was obtained prior to the 
investigations. 
RESULTS AND DISCUSSION 
'H NMR spectroscopy of cerebral metabolites 
Over the past 20 years extensive 'H NMR studies have 
been carried out to determine the visibility of mobile 
cytosolic compounds in excised tissues. In particular, 
high-resolution NMR studies at field strengths ranging 
from 7 to 14 T have revealed a large number of cerebral 
metabolites in extracts of freeze-clamped biopsy or 
autopsy specimens of mammalian brain. Figure l(a) 
shows a conventional free induction decay (FID) spec- 
trum of a perchloric acid extract of rat brain tissue at 
7.0 T. Detailed assignments of the resonances have 
been reported in the literature."' However, while these 
data may be used for the identification of singlet reso- 
nances, the chemical shift assignments for most multi- 
plet structures of spin-coupled resonances are not trans- 
ferable to lower fields. This is not due to the increased 
resonance linewidths in spectra of living tissue and 
potential complications due to signal overlap, but is 
caused by the influence of strong coupling at the rela- 
tively low field strengths of 1.0 to 4.0 T currently in use 
for human NMR spectroscopy. 
The assignment problem is illustrated by a compari- 
son of the high-field NMR spectrum shown in Fig. l(a) 
with the 2.OT brain spectra shown in Figs. l(b-d). The 
in oivo spectra were obtained from an 18mL 
(2X3x3cm')  VOI localized in the occipital gray 
matter of a 26-year-old volunteer. Straightforward 
assignments are only possible for the singlet methyl 
resonances of N-acetyl aspartate (NAA) at 2.01 pprn 
(taken as a reference), creatine (Cr) and phosphocrea- 
tine (PCr) at 3.03 ppm, and choline-containing com- 
pounds (Cho) at 3.22 ppm. Since these metabolite reso- 
nances exhibit relatively long T. relaxation times,' they 
may be specified in spectra at long echo times as shown 
in Fig. l(b) where TE = 270 ms. Their chemical shifts 
are independent of field strength and therefore agree 
with both high-field studies of extracts and preceding in 
uioo studies at l.OTV9 1.5 T,"' and 2.OT.I' On the other 
hand, the multi-component nature of the trimethyl 
ammonium resonance at 3.22 pprn is only discernible at 
high field strengths. Potential contributions from 
(glycero-) phosphorylcholine detected as prominent 
constituents of the phosphomonoester (and diester) 
resonances in roton-decoupled 31P-NMR studies of 
human brain''. "remain to be clarified. For a quantita- 
tive comparison of Figs l(a) and (b-d), it should be 
noted that the NAA/creatine and choline/creatine 
ratios are lower in rat brain than in human brain.14 A 
more detailed investigation of species-dependent meta- 
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Figure 1. 'H NMR spectra of brain tissue under different experi- 
mental conditions: (a) 7.0 T 'H NMR spectrum of a perchloric 
acid (PCA) extract of rat brain, (b-d) 2.0 T 'H NMR spectra of 
human gray matter in vivo localized in a mid-sagittal position of 
the parietal lobe of a 26-year-old volunteer (18 mL VOI, 
256 scans, TM= 30 ms). Spectrum (b) represents an acquisition 
at an echo time of T€=270 ms (TR=1600 ms). The signal 
intensities are multiplied by a factor of two as compared to 
spectrum (c) acquired at an echo time of T€=20 ms 
(TR= 1500 ms). Spectrum (d) is a magnified version of (c) 
displaying a 2.0 ppm section with the intensities being multi- 
plied by a factor of 813 as compared to (c). Resonances of 
cerebral metabolites are due to N-acetyl aspartate (NAA). crea- 
tine (Cr), and phosphocreatine (PCr), choline-containing com- 
pounds (Cho), myo-inositol (Ins), glutamate (Glu), and taurine 
(Tau). 
bolite concentrations in mammalian brains in oioo is in 
progress. 
The quality of the TE=270ms spectrum 
(TR=1600ms, 256scans) shown in Fig. l(b) corre- 
sponds to previous 'H NMR studies of human brain at 
similar echo times where signal losses due to Tz relaxa- 
tion become a dominant factor. In fact, the signal 
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amplitudes have been multiplied by a factor of two as 
compared to the spectrum shown in Fig. l(c) acquired 
at a short echo time of TE=20ms (TR=1500ms, 
256scans). In addition to an overall improvement in 
signal-to-noise, the latter spectrum exhibits a consider- 
ably increased number of resonances. Most obvious are 
the appearance of the methylene singlet resonance of 
PCr/Cr at 3.94 pprn and of a strong signal from multiple 
collapsed resonances of myo-inositol (Ins) at 3.56 pprn. 
Resonance signals from mobile lipids and/or cytosolic 
proteins were generally found to be weak.' This also 
applies to the aromatic part of the 'H NMR spectrum 
comprising the NAA amide proton (7.95 ppm) and the 
strongly coupled multiplets of adenine from adenosine 
triphosphate (8.0-8.5 pprn). 
The spectrum shown in Fig. l(d) represents a magni- 
fication of that in Fig. l(c) (amplitude factor of 8/3) 
covering a central 2 ppm frequeny range. The excellent 
signal-to-noise ratio and spectral resolution allows the 
unambiguous assignment of further strongly spin- 
coupled resonances of taurine, glutamate, and the 
aspartyl group of NAA despite the fact that the spectral 
patterns are completely different from those depicted 
at higher fields (compare Fig. l(a)). Details of the 
assignments are given in subsequent sections. 
The spurious signals of some of the spin-coupled 
metabolite resonances in spectra at longer echo times 
(e.g. compare Fig. l(b)) are barely assignable and 
theoretically hard to predict. Since their lineshapes are 
determined by a complex modulation of the distorted 
multiplet patterns observed at short echo times, and 
since this pattern never fully refocuses at any particular 
echo time, all attempts to quantify metabolite concen- 
trations from such signals must fail. The weakly cou- 
pled doublet resonances of the methyl groups of lactate 
at 1.33 ppm and alanine at 1.48 ppm represent excep- 
tional cases in which classical J modulation yields com- 
plete refocusing of the original pattern at echo times 
that are multiples of 215 for stimulated echoes and 1/J 
for spin echoes. It is therefore possible to detect these 
metabolites even in heavily T,-weighted 'H NMR spec- 
tra of cerebral  tumor^'^-'^ and after ~ t roke ." . '~  The 
strong lactate doublet in the in uirro spectrum in Fig. 
l(a) is an artifact from sample preparation due to the 
rapid onset of anerobic glycolysis in ischemic tissue. 
The low in uiuo level of cerebral lactate in normal 
human subjects (compare Fig. l(c)) as well as its 
variability and response to photic stimulation in the 
visual cortex'"." is the subject of further investigations. 
Inositol and taurine 
Strong coupling occurs when the chemical shift differ- 
ence Ad between two spin-coupled partners 
approaches the same order of magnitude as the respec- 
tive spin-spin coupling constant J, i.e., 0.1 6 J/A6 s 1. 
Since chemical shift differences in 'H NMR spectra of 
amino acids often are within 0.1-1.0 ppm, i.e., 
8-85 Hz at 2.0 T, as compared to field-independent 
homonuclear coupling constants of 7 f 2 Hz, strongly 
coupled multiplet resonances are the rule rather than 
the exception for most spin-coupled 'H NMR reso- 
nances. The resulting multiplets exhibit major distor- 
tions relative to high-field spectra including variations 
in the number of resonance lines as well as in the 
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Figure2. 'H NMR spectra of an aqueous solution of myo- 
inositol at (a) 7.0 T and (b, c) 2.0 T in comparison to (d) a 2.0 T 
'H NMR spectrum of human brain in vivo: (a) fully relaxed FID 
spectrum of myo-inositol (pH 7.1, 50 mM, 7.0 T, * acetate refer- 
ence), (b) fully relaxed, localized STEAM spectrum of myo- 
inositol (8 mL VOI, T f = 2 0  ms, pH 7.1, 100 rnM in a 250 mL 
beaker, 2.0 TI, and (c) linebroadened version of spectrum (b) to 
mimic the linewidths obtained in spectra of human brain in v iva  
(d) 'H NMR spectrum of human brain in vivo localized in the 
thalamus of a 4-year-old patient without pathological findings 
(8 mL VOI, Tf = 20 ms, TR= 1500 ms, 256 scans, 2.0 T). 
intensities and chemical shift values. A further con- 
sequence is the distortion of the linear relation- 
ship between peak area and number of spins which 
needs to be accounted for when evaluating metabolite 
concentrations. 
Impressive examples for the qualitative spectral 
alterations that have to be dealt with in low-field in uiuo 
NMR spectra are demonstrated in Figs 2 and 3 for myo- 
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Figure 3. 'H NMR spectra of an aqueous solution of taurine at 
(a) 7.0 T and (b, c) 2.0 T in comparison to (d) a 2.0 T 'H NMR 
spectrum of human brain in vivo: (a) fully relaxed FID spectrum 
of taurine (pH 7.2, 50 mM, 7.0 T, * lactate reference), (b) fully 
relaxed, localized STEAM spectrum of taurine (8 mL VOI, 
T€=20 ms, pH 7.2, 50 mM in a 250 mL beaker, 2.0 T), (c) 
linebroadened version of spectrum (b), and (d) 'H NMR spec- 
trum of human brain in vivo localized in the parietal white 
matter of a 4-year-old patient without pathological findings 
(8 mL VOI, Tf = 20 ms, TR= 1500 ms, 256 scans, 2.0 TI. 
inositol and taurine, respectively. In both cases, con- 
siderable lineshape variations are observed in going 
from a 7.0 T FID spectrum (Figs 2(a), 3(a)) to a 2.0 T 
localized STEAM spectrum at an echo time of TE= 
20ms (Figs 2(b), 3(b)). The 8 m L  VOI was chosen 
inside a 250 mL beaker of an aqueous metabolite solu- 
tion positioned in the center of the whole-body magnet. 
These conditions correspond to the situation encoun- 
tered for in uiuo ' H  NMR studies of human brain. 
For myo-inositol the main resonance at 3.56 ppm 
originates from a collapse of the H1,H3 and H4,H6 
multiplets seen at 7.0 T." The intensity of the distorted 
H5 triplet at 3.28 ppm is significantly reduced at 2.0 T, 
while the less strongly coupled H2 triplet at 4.06 ppm 
remains. In the taurine spectrum the distorted N-CH2 
(3.26 ppm) and S-CH2 (3.43 ppm) triplets at 7.0 T 
merge to an apparent quartet at 2.0 T with effective 
chemical shifts of 3.26, 3.32, 3.38, and 3.43 ppm. 
The spectra in Figs 2(c), 3(c) represent artificially 
linebroadened versions of the 2.0 T metabolite spectra 
in Figs 2(b), 3(b) to mimic the in vivo linewidths and 
the influence of limited resolution. Obviously, the 
enhanced filtering by Gaussian multiplication (3.6 Hz 
linebroadening) results in improved signal-to-noise 
ratios, while the peak intensities of the sharp reso- 
nances in Figs 2(b), 3(b) drop when using the same 
amplitude scale. The lower parts of Figs 2, 3 offer a 
comparison between the linebroadened metabolite 
spectra and in viuo 'H NMR brain spectra (8 mL VOI, 
TE = 20 ms) of a 4-year-old child (Figs 2(d), 3(d)). In 
fact, both inositol and taurine resonances were found to 
be higher in spectra obtained from children than from 
adults. The spectrum in Fig. 2(d) was localized in the 
thalamus, while Fig. 3(d) refers to a location in the 
parietal white matter of one hemisphere. 
It should be noted that the in uiuo resonances of 
inositol and taurine partially overlap those from other 
metabolites. This particularly applies to the taurine 
resonances at 3.26 and 3.32ppm which in most cases 
are covered by the choline-containing signals at 
3.22 ppm as, for example, seen in the spectrum of the 
adult human brain shown in Fig. l(d). The weak 
resonances of inositol at 3.65 and 3.77 ppm overlap 
with the 3.68 and 3.75ppm resonances of the less 
strongly coupled a-CH triplet of glutamate (see below). 
It is further noteworthy that the in uiuo resonance 
linewidths are significantly broader than those obtained 
from metabolite solutions under identical experimental 
conditions. Thus, the resolution of the human brain 
spectra presented here is determined by biological 
susceptibility differences rather than limited by mag- 
netic field inhomogeneities of the whole-body magnet. 
The origin of the in uiuo inositol signal is expected to 
be largely due to myo-inositol. Significant contributions 
from inositol headgroups of membrane-bound 
phospholipidsz3 or inositol phosphate24 can be excluded 
on the basis of their different 'H NMR spectra, e.g., for 
the chemical shift of the H2 resonance at 4.06ppm. 
This finding is further supported by the fact that homo- 
nuclear off-resonance irradiation did not show a 
decrease of any 'H NMR visible metabolite resonances 
in the human brain, while the water signal was con- 
siderably reduced by a transfer of saturated magnetiz- 
ation from macromolecular structures to neighboring 
water molecules. Thus, the observed inositol reso- 
nances are not in close contact with immobilized mem- 
brane structures as would be the case for phospholipid 
inositols . 
Glutamate and N-acetyl aspartate 
The methylene resonances of both glutamate and the 
aspartyl group of NAA represent further examples of 
strongly spin-coupled multiplet patterns at 2.0 T. The 
fully relaxed, localized STEAM spectra (8 mL VOI, 
TE = 20 ms) shown in Fig. 4 are from aqueous model 
solutions of glutamate (Fig. 4(a)) and a 1:l mixture of 
glutamate and NAA (Fig. 4(b)). Obviously, the appar- 
ently low 'visibility' of glutamate relative to the single 
methyl resonance of NAA at 2.01 ppm may be entirely 
attributed to a distribution of its intensities into a large 
number of multiplet resonances. In the linebroadened 
version shown in Fig. 4(c), the glutamate spectrum 
yields four major resonance lines at 2.12, 2.18, 2.28, 
and 2.36 ppm in addition to three resonances from the 
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Figure 4. 2.0 T localized 'H NMR spectra of aqueous solutions 
of (a) glutamate and (b, c) mixtures of glutamate and NAA in 
comparison to (d) a 'H NMR spectrum of human brain in vivo: 
(a) fully relaxed, localized STEAM spectrum of glutamate (8 mL 
VOI, T€=20 ms, pH 7.2, 50 mM in a 250 rnL beaker), (b) fully 
relaxed, localized STEAM spectrum of a 1 : l  mixture of gluta- 
mate and NAA (8 mL VOI, T€= 20 ms, pH 7.2, both metabolites 
at 50 mM in a 250 mL beaker), (c) linebroadened version of 
spectrum (b), and (d) 'H NMR spectrum of human gray matter in 
vivo localized in a mid-sagittal position of the parietal lobe of a 
56-year-old volunteer (18 mL VOI, T€=20 ms, TR=3000 ms, 
128 scans). 
NAA aspartyl group at 2.48, 2.60 and 2.66ppm. All 
these resonances as well as the less strongly coupled 
a-CH triplet of glutamate centered at 3.75 ppm are 
clearly identifiable in 'H NMR spectra of human brain. 
This not only applies to the in uiuo spectrum of a 56- 
year-old volunteer as shown in Fig. 4(d) where the VOI 
was localized in the occipital gray matter in a mid- 
sagittal position of the parietal lobe, but also to other 
brain spectra from gray and white matter shown in Figs 
l(d)-3(d) and 6(d), respectively. 
The obvious coincidence between the NAA/ 
glutamate model solution and the in uiuo findings has 
consequences for a discussion of the relative concentra- 
tions of NAA and glutamate in human brain in uiuo. 
First of all, the relative intensities of the NAA aspartyl 
signals are in full agreement with the intensity of the 
NAA singlet resonance at 2.01 ppm. The in uiuo find- 
ings have been further confirmed by the acquisition of 
fully relaxed spectra ( T R  = 6OOO ms) from parietal 
white matter in 20-30-year-old volunteers (20 cases). 
Thus, the 2.01 pprn signal must be entirely attributed to 
NAA unless another mobile metabolite exists that 
exhibits an identical resonance pattern but which is not 
detectable in tissue extracts. Secondly, despite the fact 
that glutamate yields significantly lower resonance 
signals than NAA, its concentration is only slightly 
lower than that of NAA. This finding is supported by a 
qualitative comparison of respective lineshapes and 
intensity ratios of the 1:l NAA/glutamate spectrum in 
Fig. 4(c) with the in uiuo spectral behavior shown in 
Figs l(d)-4(d) and 6(d). Thirdly, no glutamine reso- 
nances are detectable in normal human brain in uiuo. 
Based on the actually achieved signal-to-noise ratio the 
in uiuo glutamine level must be at least five times lower 
than that of glutamate (see also below). 
Glutamine 
The low level of cerebral glutamine in normal human 
brain means that there is considerable potential for its 
detection in pathological circumstances. In analogy to 
previous figures, this section outlines the glutaniine 
spectral behavior at 2.0 T under the experimental con- 
ditions of a STEAM localization sequence. Figures 
5(a), (b) depict fully relaxed, localized STEAM spectra 
of an aqueous model solution of glutamine (SmL, 
TE = 20 ms) and its linebroadened version, respec- 
tively. The resulting pattern comprises four major reso- 
nance signals at 2.06, 2.16, 2.37, and 2.45ppm. The 
latter two resonances and their corresponding ampli- 
tudes differ sufficiently from both the y-CH- resonances 
of glutamate and the NAA aspartyl pattern. This find- 
ing allows the identification of glutamine in the pres- 
ence of NAA and glutamate, and provides the basis for 
a determination of their relative contributions. 
This capability is demonstrated in Fig. 5(c). The 
spectrum represents a line-broadened version of a 1: 1: 1 
mixture of glutamine, glutamate, and NAA (8mL 
VOI, TE = 20 ms) and may be directly compared to the 
binary mixture of glutamate and NAA depicted in Fig. 
4(c). While the glutamate and glutamine triplet reso- 
nances (3.75ppm, 3.77ppm) as well as the effective 
f3-CH2 resonances overlap in a constructive way relative 
to the NAA intensities at 2.01 and 2.60ppm. the 
presence of glutamine is clearly manifested by its over- 
lap to the 2.48ppm NAA aspartyl resonance and the 
2.36 pprn y-CH2 resonance of glutamate. This results in 
a characteristic change of the multiplet pattern relative 
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Figure 5. 2.0 T localized 'H NMR spectra of aqueous solutions 
of (a, b) glutamine and (c) a mixture of glutamine, glutamate, 
and NAA in comparison to (d) a 'H NMR spectrum of human 
brain in vivo: (a) fully relaxed, localized STEAM spectum of 
glutamine (8 mL VOI, E = 2 0  ms, pH 7.2, 50 mM in a 250 mL 
beaker), (b) line-braodened version of spectrum (a), (c) line- 
broadened version of a fully relaxed, localized STEAM spectrum 
of a 1:l:l mixture of glutamine, glutamate, and NAA (8 mL VOI, 
T€=20 rns, pH 7.2, all metabolites at 50 mM ina 250 mL beaker), 
and (d) 'H NMR spectrum of human gray matter in vivo localized 
in a mid-sagittal position of the parietal lobe of a 27-year-old 
patient presenting with liver cirrhosis (18 mL VOI, T€=20 ms, 
TR= 3000 ms, 128 scans). 
to that observed in Fig. 4(c) as well as in all other 
human brain spectra shown in this paper (Figs l(d)- 
4 ( 4 ,  6d). 
The altered glutamine/glutamate spectral pattern 
becomes obvious in the in oioo spectrum of a 27-year- 
old patient with liver cirrhosis of infectious origin 
shown in Fig. 5(d). The increase of cerebral glutamine 
was detected by localizing (18 mL VOI, TE = 20 ms) in 
an occipital gray matter region similar to that used in 
Fig. 4(d). With references to the 1 : l  ratio of glutamine 
to glutamate in Fig. 5(c), the relative concentration of 
glutamine in the patient is estimated to be about 75% 
of the glutamate concentration. It is believed that 
severe liver damage may cause an increase of ammonia 
in the systemic blood pool leading to an increased 
synthesis of glutamine in astrocytes, i.e., in gray matter 
regions of the brain. A full report on the alterations of 
cerebral metabolites in patients with severe liver dis- 
eases will be given elsewhere. A case report on the 
increase of cerebral glutamine in hepatic encephalo- 
pathy has been published by Kreis et ~ 1 . ~  
Intracellular brain glucose 
None of the previous 'H NMR spectra of human brain 
in uiuo exhibited intracellular brain glucose levels that 
were sufficiently high to be detected. However, 
patients with diabetes suffer from elevated blood glu- 
cose concentrations that may lead to an enhanced brain 
glucose concentration. The 'H NMR spectrum of glu- 
cose is already strongly coupled at a field strength of 
7.OT as shown in Fig. 6(a). In close analogy to the 
observations for inositol and taurine in Figs 2 and 3, the 
fully relaxed, localized 2.0 STEAM spectrum of an 
aqueous solution of glucose (8 mL VOI, TE = 20 ms) 
shown in Fig. 6(b) differs significantly from the high- 
field results. In particular, the signal at about 3.25 pprn 
almost vanishes, while the remaining complex spectral 
ranges simplify to an apparent singlet at 3.43 pprn and 
an apparent triplet at 3.80 ppm. 
In order to relate the glucose resonance intensities to 
those of other cerebral metabolites, Fig. 6(c) shows a 
linebroadened version of a fully relaxed, localized 2.0 T 
STEAM spectrum (8 mL, TE = 20 ms) of an aqueous 
solution of a 1:2 mixture of glucose and NAA. These 
results may be compared to the in uioo spectrum of a 
69-year-old diabetic shown in Fig. 6(d). Elevated glu- 
cose levels were found when localizing (18 mL VOI, 
TE = 20 ms) to a gray matter region in a mid-sagittal 
position of the occipital part of the partial lobe. The 
3.43 ppm resonance of glucose clearly overlaps with a 
taurine resonance at the same chemical shift, while the 
apparent triplet at 3.80 ppm adds to the a-CH triplet of 
glut amate. 
The patient presented with a blood glucose level of 
8.3 mM. According to the model solutions and in par- 
ticular with reference to the spectrum shown in Fig. 
6(c), the observed glucose intensity corresponds to an 
intracellular concentration of about 50% of the NAA 
concentration, i.e., about 9 mM assuming a 10 mM con- 
centration of total creatine (see below). A more 
detailed study of the regional distribution and absolute 
concentrations of brain glucose in patients with dia- 
betes as well as the correlation with plasma values will 
be reported elsewhere. Enhanced levels of brain glu- 
cose were also found in cerebral tumors (e.g., astrocy- 
tomas) and surrounding edematous tissues' as well as in 
the cerebrospinal fluid in uiuo from a VOI localized in 
the ventricles. 
Summary of chemical shifts at 2.0 T 
A summary of the chemical shifts of cerebral metabo- 
lites as observed in 'H NMR spectra of human brain in 
oiuo is given in Table 1 for a field strength of 2.0 T.  The 
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chemical shifts of singlet resonances and of weakly 
coupled multiplet resonances are field-independent and 
therefore agree with the data obtained at higher fields. 
On the other hand, the values reported for strongly 
* 
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Figure 6. 'H NMR spectra of an aqueous solution of glucose at 
(a) 7.0 T and (b, c) 2.0 T in comparison to (d) a 2.0 T 'H NMR 
spectrum of human brain in vivo: (a) fully relaxed FID spectrum 
of glucose (pH 7.2, 50 mM, 7.0 T, * acetate reference), (b) fully 
relaxed, localized STEAM spectrum of glucose (8 mL VOI, 
T€=20 ms, pH 7.2, 15 mM in a 250 mL beaker, 2.0 T, acetate 
reference), (c) fully relaxed, localized STEAM spectrum of a 1:2 
mixture of glucose and NAA (8 mL VOI, T€=20 ms, pH 7.3, 
15 mM glucose and 30 mM NAA in a 250 mL beaker, 2.0 T), (c) 
linebroadened version of spectrum (b), and (d) 'H NMR spec- 
trum of human gray matter in vivo localized in a mid-sagittal 
position of the parietal lobe of a 69-year-old patient with 
diabetes mellitus presenting with a plasma glucose level of 
8.3 mM (18 mLVOI, E = 2 0  ms, TR=3000 ms, 128 scans, 2.0 T). 
Table 1. Chemical shifts 6 and multiplicities m of 'H NMR 
resonances of cerebral metabolites as detected in 
7.0 T FID spectra of model solutions and in 2.0 T 
localized STEAM spectra (TE=20ms) of human 
brain in vivo 
Molecular da, rnb bC 
Metabolite group 7.0 T 2.0 T 
Lactate CH3 1.33.d 1.33 
Alanine CH3 1.48.d 1.48 
NAA CH3 2.01 ,s 2.01 
Glutamate B-CH2 2.09,~ 2.0012.0512.i212.ia 
CH2 2.4912.67.ddldd 2.4812.6012.66 
2.2812.3612.45 -- Y-CH2 2.36,t 
a-CH 3.75,c 3,6813.7513.82 
Y-CHz 2.45,t -- 2.3712.4512.55 
a-CH 3.77,c 3.7013.7713.85 
Glutamine P-CH2 2.13,~ 1.9712.06/2.16r'2.24 
PCrlCr CH3 3.05.s/3.03,s 3.03 
CHZ 3.96.sI3.93,~ 3.94 
Cholines N-(CH,), 3.19-3.25 3.22 
Taurine N-CHzIS-CH2 3.26.tl3.43,t 3.2613.3213.38i3.43 
Glucose H2-6 3.21-3.93,~ -- 3.4313.80 
myo-lnositol H5 3.28.t 3.28 
H1.3/H4,6 3.52.dd13.62,t 3.5613.6513.77 
H2 4.06.t 4.06 
a Chemical shifts are given in ppm and referenced to 2.01 ppm 
for the CH, resonance of N-acetyl aspartate (NAA). 
s: Singlet, d: doublet, t: triplet, dd: two doublets, c: complex. 
Major resonances of strongly spin-coupled multiplets are 
underlined. The spectral resolution corresponds to kO.01 ppm. 
spin-coupled resonances refer to the effective chemical 
shifts of apparent resonance lines representing the dis- 
torted multiplets as they appear at 2.0T. Since tbese 
shifts depend on the actual field strength, their identifi- 
cation has to be repeated for other field. strengths. 
Although similar results may be expected, even minor 
field changes lead to slightly different spectral patterns 
as has been observed at 2.35T in localized STEAM 
spectra (TE=20ms) of rat brain in uiuo.'' 
It should be noted that field strengths of 4 to 7 T will 
be unable to solve the problem of strong coupling for 
inositol, taurine, glutamate, glutamine, and glucose. In 
fact, higher fields may introduce even more complica- 
tions for an unambiguous identification of tissue meta- 
bolites due to an increased sensitivity to motion and 
susceptibilities. They also tend to increase the number 
of resonance lines and therefore complicate the result- 
ing multiplet patterns. On the other hand, low field 
strengths in the 1.5 to 2.35 T range generally lead to a 
significant spectral simplification as demonstrated in 
Figs 1-6. 
CONCLUSION 
~ ~ ______ 
The identification problems associated with spectral 
alterations in 'H NMR spectra at low fields versus high 
fields, may be overcome by qualitative assignments 
through lineshape comparisons of spectra obtained of 
metabolite solutions in uitro and of human brain in 
uiuo, respectively. However, since even minor varia- 
tions of the field strength may cause spectral changes in 
the presence of strong spin-spin coupling, the present 
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data are only valid for a field strength of 2.0 T. Another 
consequence of the results is that, with the prominent 
exception of lactate, homonuclear editing techniques 
with evolution periods of the order of 1/J will not be 
applicable to cerebral metabolites. Their unavoidable 
T, losses and the incomplete refocusing of multiplets 
due to complex J modulation are clearly demonstrated 
in Fig. 1. 
The identification and detailed understanding of the 
spectral appearance of a particular metabolite is a 
prerequisite for a quantification of its absolute concen- 
tration in v i m .  Current efforts focus on the establish- 
ment of the biological reproducibility, the regional 
distribution, the age dependence, and the physiological 
variability of brain spectra using a large number of 
volunteers. In addition, alternative strategies are tested 
for consistency of absolute metabolite quantifications. 
So far, relative concentrations of cerebral metabolites 
may be reported that are based on a comparison of 
metabolite spectra with fully relaxed (TR = 6OOO ms, 
20cases) 'H NMR spectra of white matter in the 
parietal lobe of young adults. Assuming total creatine 
to be about 10 mM, the relative values are 18.9 mM for 
NAA,  3 . 2 m ~  for cholines, 11.1 mM for glutamate, 
7.0 mM for inositol, and 7.4 mM for taurine. The con- 
centrations of glutamine and glucose are too low to be 
detected under normal conditions. Cerebral lactate 
varies depending on the physiological state. 
The various studies described above are necessary 
prerequisites for the undertaking of meaningful clinical 
trials. Anything less may compromise results and 
thereby jeopardize the development of in oivo NMR 
spectroscopy as a unique tool for noninvasive metabolic 
studies in man. 
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